Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin + Triple Therapy for H. pylori Eradication
NCT03124199Phase 3Completed
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
- Start
- Feb 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifaximin in Helicobacter pylori infection, sponsored by Fundación de Investigación Biomédica del Hospital Universitario de La Princesa. Started Feb 2014; status: completed.
02
Drugs
rifaximin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03124199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03124199.